UBQLN2 and amyotrophic lateral sclerosis: ATP6V1G1 overexpression due to UBQLN2 mutations has been found to cause amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegeneration [11].